Citigroup Boosts Baxter International (NYSE:BAX) Price Target to $40.00
Baxter International (NYSE:BAX – Free Report) had its price target increased by Citigroup from $38.00 to $40.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock. BAX has been the subject of several other reports. Wells Fargo & Company reduced their […]
More Stories
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $53.00
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada...
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $53.00
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada...
Atmos Energy Co. (NYSE:ATO) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Atmos Energy Co. (NYSE:ATO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the...
Atmos Energy Co. (NYSE:ATO) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Atmos Energy Co. (NYSE:ATO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the...
Analysts Set Tidewater Inc. (NYSE:TDW) Price Target at $111.25
Tidewater Inc. (NYSE:TDW – Get Free Report) has received an average rating of “Buy” from the five ratings firms that...
Analysts Set Tidewater Inc. (NYSE:TDW) Price Target at $111.25
Tidewater Inc. (NYSE:TDW – Get Free Report) has received an average rating of “Buy” from the five ratings firms that...